Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$113,266
-$1,027,952 QoQ
Shares Held
12,140
-89.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#367
of 639 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Calydon Capital holds $113,266 across 1 Drug Manufacturers - Specialty & Generic name. HLN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
This page
|
12,140 | $113,266 |
All Filings in HLN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $113,266 | 12,140 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $1,141,218 | 110,050 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $509,015 | 49,467 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $471,915 | 49,467 | Shares | Sole | 2025-02-18 | |
| No filing history on record for this holder in this stock. | ||||||